Overactive Bladder - Results from #1780

Sacral neuromodulation for refractory overactive bladder, interstitial cystitis, and painful bladder syndrome - Abstract December 5, 2013

Overactive bladder in cervical spondylotic myelopathy - Abstract December 5, 2013

Evaluation of fesoterodine fumarate for the treatment of an overactive bladder - Abstract December 3, 2013

Antimuscarinic persistence patterns in newly treated patients with overactive bladder: A retrospective comparative analysis - Abstract December 2, 2013

Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate - Abstract November 29, 2013

Urinary bladder drugs - Abstract November 28, 2013

A randomised, double-blind, parallel design, multi-institutional, non-inferiority phase IV trial of imidafenacin versus fesoterodine for overactive bladder - Abstract November 27, 2013

Electrical and mechanical office-based neuromodulation - Abstract November 26, 2013

Important drug-drug interactions for treatments that target overactive bladder syndrome - Abstract November 26, 2013

Repeated botulinum toxin type A (Dysport®) injections for women with intractable detrusor overactivity: A prospective outcome study - Abstract November 25, 2013

Pharmacokinetics of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder, in healthy Japanese male subjects: Results from single- and multiple-dose studies - Abstract November 23, 2013

Cost-effectiveness of test phase implantation strategies for InterStim® sacral neuromodulation - Abstract November 21, 2013

Defining response and non-response to treatment in patients with overactive bladder: A systematic review - Abstract November 20, 2013

Does concomitant diabetes affect treatment responses in overactive bladder patients? - Abstract November 19, 2013

Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States - Abstract November 18, 2013

How to define a refractory idiopathic overactive bladder? - Abstract November 15, 2013

Solifenacin in women with de novo overactive bladder post TVT-O: Is it effective? - Abstract November 15, 2013

Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain - Abstract November 14, 2013

Effectiveness of retropubic tension-free vaginal tape and transobturator inside-out tape procedures in women with overactive bladder and stress urinary incontinence - Abstract November 12, 2013

Long-term adherence to antimuscarinic therapy in everyday practice: A systematic review - Abstract November 11, 2013

Page 90 of 121